HealthSouth (HLS) EPS Estimated At $0.69, Myos Rens Tech (MYOS) Shorts Decreased By 17.73%

June 30, 2017 - By Henry Gaston

Analysts expect HealthSouth Corp (NYSE:HLS) to report $0.69 EPS on July, 27.They anticipate $0.00 EPS change or 0.00% from last quarter’s $0.69 EPS. HLS’s profit would be $62.26M giving it 17.59 P/E if the $0.69 EPS is correct. After having $0.70 EPS previously, HealthSouth Corp’s analysts see -1.43% EPS growth. The stock decreased 0.57% or $0.28 during the last trading session, reaching $48.54. About shares traded. HealthSouth Corp (NYSE:HLS) has risen 15.04% since June 30, 2016 and is uptrending. It has underperformed by 1.66% the S&P500.

Myos Rens Tech Incorporated (NASDAQ:MYOS) had a decrease of 17.73% in short interest. MYOS’s SI was 492,000 shares in June as released by FINRA. Its down 17.73% from 598,000 shares previously. With 116,100 avg volume, 4 days are for Myos Rens Tech Incorporated (NASDAQ:MYOS)’s short sellers to cover MYOS’s short positions. The SI to Myos Rens Tech Incorporated’s float is 13.88%. The stock increased 2.30% or $0.04 on June 29, reaching $1.78. About shares traded. MYOS RENS Technology Inc (NASDAQ:MYOS) has risen 31.03% since June 30, 2016 and is uptrending. It has outperformed by 14.33% the S&P500.

MYOS RENS Technology Inc. , formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The company has market cap of $10.34 million. The Firm is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. It currently has negative earnings. The Firm is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue.

HealthSouth Corporation is a well-known provider of post-acute healthcare services, offering both facility and home post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company has market cap of $4.38 billion. The Firm manages its activities through divisions, including inpatient rehabilitation, and home health and hospice. It has a 18.46 P/E ratio. It is an owner and operator of inpatient rehabilitation hospitals.

Among 12 analysts covering Healthsouth (NYSE:HLS), 4 have Buy rating, 1 Sell and 7 Hold. Therefore 33% are positive. Healthsouth had 19 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, October 29 by Stifel Nicolaus. The rating was maintained by Mizuho with “Buy” on Thursday, October 29. Barclays Capital downgraded the stock to “Underweight” rating in Monday, June 27 report. The firm has “Buy” rating by Mizuho given on Friday, April 29. The company was maintained on Friday, July 31 by RBC Capital Markets. Mizuho maintained HealthSouth Corp (NYSE:HLS) on Wednesday, February 22 with “Neutral” rating. The stock of HealthSouth Corp (NYSE:HLS) earned “Neutral” rating by Piper Jaffray on Wednesday, January 4. The firm earned “Outperform” rating on Monday, February 27 by RBC Capital Markets. The firm earned “Outperform” rating on Monday, October 31 by RBC Capital Markets. The company was downgraded on Wednesday, November 9 by Mizuho.

Investors sentiment increased to 2.02 in Q4 2016. Its up 0.87, from 1.15 in 2016Q3. It is positive, as 21 investors sold HealthSouth Corp shares while 67 reduced holdings. 66 funds opened positions while 112 raised stakes. 88.03 million shares or 7.03% more from 82.25 million shares in 2016Q3 were reported. Waddell Reed Fin reported 0.02% in HealthSouth Corp (NYSE:HLS). Verition Fund Mngmt Llc holds 0.05% or 15,458 shares in its portfolio. Ameritas Investment Partners holds 0.07% or 34,693 shares. Macquarie Gru Ltd holds 507,135 shares. Mutual Of America Capital Limited Liability Company stated it has 70,767 shares. Frontier Limited Liability has 304,761 shares. Valley Advisers holds 0% or 49 shares. Rafferty Asset Management Limited Liability Company reported 0.22% of its portfolio in HealthSouth Corp (NYSE:HLS). Clarivest Asset Mgmt Ltd Liability Corporation holds 0.02% of its portfolio in HealthSouth Corp (NYSE:HLS) for 17,581 shares. Proshare Ltd Llc owns 24,316 shares. Morgan Stanley invested in 445,238 shares or 0.01% of the stock. Coastland Capital Ltd Liability has 62,275 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv holds 81,480 shares. Price T Rowe Associate Md, a Maryland-based fund reported 963,092 shares. Blackrock Grp Inc Ltd, a United Kingdom-based fund reported 71,703 shares.